19.54 USD
▲-0.05+4.05%
盘后 18.72 -0.32%
2026-08-03
市值
$4.26B
市盈率
—
EPS
-1.56
股息率
—
52 周区间
3.03 – 20.79
成交量
2.05M
Beta
1.68
目标价
26.08
52W 低 3.0352W 高 20.79
价格走势
公司简介
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company’s lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Kα, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and αGal chaperone for Fabry diseases. It also develops R...